Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 4677

1.

The small molecule NSM00191 specifically represses the TNF-α/NF-кB axis in foot and ankle rheumatoid arthritis.

Wen X, Chen X, Liang X, Zhao H, Li Y, Sun X, Lu J.

Int J Biol Sci. 2018 Oct 3;14(12):1732-1744. doi: 10.7150/ijbs.24232. eCollection 2018.

2.

TWEAK/Fn14 Interaction Confers Aggressive Properties to Cutaneous Squamous Cell Carcinoma.

Hu G, Liang L, Liu Y, Liu J, Tan X, Xu M, Peng L, Zhai S, Li Q, Chu Z, Zeng W, Xia Y.

J Invest Dermatol. 2018 Nov 8. pii: S0022-202X(18)32795-7. doi: 10.1016/j.jid.2018.09.035. [Epub ahead of print]

PMID:
30414907
3.

Exclusive expression of transmembrane TNF aggravates acute glomerulonephritis despite reduced leukocyte infiltration and inflammation.

Müller MB, Hoppe JM, Bideak A, Lux M, Lindenmeyer MT, Müller S, Eltrich N, Ryffel B, Vielhauer V.

Kidney Int. 2018 Oct 30. pii: S0085-2538(18)30594-5. doi: 10.1016/j.kint.2018.08.012. [Epub ahead of print]

PMID:
30389199
4.

Platelet activity is negatively modulated by tumor necrosis factor alpha through reductions of cytosolic calcium levels and integrin alphaIIbbeta3 phosphorylation.

Bonfitto PHL, Naime ACA, Lopes-Pires ME, Goulart G, Mendes-Silverio CB, Bueno PI, Castilho RF, Antunes E, Marcondes S.

Thromb Res. 2018 Oct 9;172:44-50. doi: 10.1016/j.thromres.2018.10.008. [Epub ahead of print]

PMID:
30359790
5.

Targeted killing of TNFR2-expressing tumor cells and Tregs by TNFR2 antagonistic antibodies in advanced Sézary syndrome.

Torrey H, Khodadoust M, Tran L, Baum D, Defusco A, Kim YH, Faustman DL.

Leukemia. 2018 Oct 24. doi: 10.1038/s41375-018-0292-9. [Epub ahead of print]

PMID:
30356161
6.

Association between circulating tumor necrosis factor-related biomarkers and estimated glomerular filtration rate in type 2 diabetes.

Kamei N, Yamashita M, Nishizaki Y, Yanagisawa N, Nojiri S, Tanaka K, Yamashita Y, Shibata T, Murakoshi M, Suzuki Y, Gohda T.

Sci Rep. 2018 Oct 17;8(1):15302. doi: 10.1038/s41598-018-33590-w.

7.

Immature lung TNFR2- conventional DC 2 subpopulation activates moDCs to promote cyclic di-GMP mucosal adjuvant responses in vivo.

Mansouri S, Patel S, Katikaneni DS, Blaauboer SM, Wang W, Schattgen S, Fitzgerald K, Jin L.

Mucosal Immunol. 2018 Oct 16. doi: 10.1038/s41385-018-0098-0. [Epub ahead of print]

PMID:
30327534
8.

Significant induction of soluble TNFR2 compared with TNFR1 in serum samples of HIV patients with or without antiretroviral medication

Sarfo B, Haile Z, Deletsu S, Mensah EA, Bonney EY.

Infect Disord Drug Targets. 2018 Oct 16. doi: 10.2174/1871526518666181016110409. [Epub ahead of print]

PMID:
30324895
9.

Tumor necrosis factor receptor superfamily members 1a and 1b contribute to exacerbation of atherosclerosis by Chlamydia pneumoniae in mice.

Zafiratos MT, Cottrell JT, Manam S, Henderson KK, Ramsey KH, Murthy AK.

Microbes Infect. 2018 Oct 4. pii: S1286-4579(18)30152-7. doi: 10.1016/j.micinf.2018.09.003. [Epub ahead of print]

PMID:
30292879
10.

Polymorphic Variants of TNFR2 Gene in Schizophrenia and Its Interaction with -308G/A TNF-α Gene Polymorphism.

Suchanek-Raif R, Raif P, Kowalczyk M, Paul-Samojedny M, Kucia K, Merk W, Kowalski J.

Mediators Inflamm. 2018 Sep 4;2018:8741249. doi: 10.1155/2018/8741249. eCollection 2018.

11.

Monovalent TNF receptor 1-selective antibody with improved affinity and neutralizing activity.

Richter F, Zettlitz KA, Seifert O, Herrmann A, Scheurich P, Pfizenmaier K, Kontermann RE.

MAbs. 2018 Sep 25:1-12. doi: 10.1080/19420862.2018.1524664. [Epub ahead of print]

PMID:
30252601
12.

Anti-TNFR1 targeting in humanized mice ameliorates disease in a model of multiple sclerosis.

Williams SK, Fairless R, Maier O, Liermann PC, Pichi K, Fischer R, Eisel ULM, Kontermann R, Herrmann A, Weksler B, Romero N, Couraud PO, Pfizenmaier K, Diem R.

Sci Rep. 2018 Sep 11;8(1):13628. doi: 10.1038/s41598-018-31957-7.

13.

TNFR2 unlocks a RIPK1 kinase activity-dependent mode of proinflammatory TNFR1 signaling.

Siegmund D, Ehrenschwender M, Wajant H.

Cell Death Dis. 2018 Sep 11;9(9):921. doi: 10.1038/s41419-018-0973-3.

14.

Progranulin Promotes Regeneration of Inflammatory Periodontal Bone Defect in Rats via Anti-inflammation, Osteoclastogenic Inhibition, and Osteogenic Promotion.

Chen Q, Cai J, Li X, Song A, Guo H, Sun Q, Yang C, Yang P.

Inflammation. 2018 Sep 5. doi: 10.1007/s10753-018-0886-4. [Epub ahead of print]

PMID:
30187338
15.

Design and synthesis of a luminescent iridium complex-peptide hybrid (IPH) that detects cancer cells and induces their apoptosis.

Masum AA, Yokoi K, Hisamatsu Y, Naito K, Shashni B, Aoki S.

Bioorg Med Chem. 2018 Sep 15;26(17):4804-4816. doi: 10.1016/j.bmc.2018.08.016. Epub 2018 Aug 14.

PMID:
30177492
16.

Effects of human umbilical cord blood CD34+ cell transplantation in neonatal hypoxic-ischemia rat model.

Yu Y, Yan Y, Luo Z, Luo P, Xiao N, Sun X, Cheng L.

Brain Dev. 2018 Aug 31. pii: S0387-7604(18)30425-X. doi: 10.1016/j.braindev.2018.08.007. [Epub ahead of print]

PMID:
30177297
17.

Clinical significance of tumor necrosis factor receptor 2 in middle and lower thoracic esophageal squamous cell carcinoma.

Yang D, Li R, Wang H, Wang J, Li Y, Wang H, Wang W, Liu Z.

Oncol Lett. 2018 Sep;16(3):2971-2978. doi: 10.3892/ol.2018.8998. Epub 2018 Jun 20.

18.

TNFR2 ligation in human T regulatory cells enhances IL2-induced cell proliferation through the non-canonical NF-κB pathway.

Wang J, Ferreira R, Lu W, Farrow S, Downes K, Jermutus L, Minter R, Al-Lamki RS, Pober JS, Bradley JR.

Sci Rep. 2018 Aug 13;8(1):12079. doi: 10.1038/s41598-018-30621-4.

19.

iRhom2 promotes atherosclerosis through macrophage inflammation and induction of oxidative stress.

Chaohui C, Wei H, Hongfeng W, Yueliang Z, Xiaoqin P, Pingli Z, Zhibing A.

Biochem Biophys Res Commun. 2018 Sep 10;503(3):1897-1904. doi: 10.1016/j.bbrc.2018.07.133. Epub 2018 Aug 7.

PMID:
30097271
20.

Critical Role of Tumor Necrosis Factor Signaling in Mesenchymal Stem Cell-Based Therapy for Autoimmune and Inflammatory Diseases.

Yan L, Zheng D, Xu RH.

Front Immunol. 2018 Jul 20;9:1658. doi: 10.3389/fimmu.2018.01658. eCollection 2018. Review.

Supplemental Content

Loading ...
Support Center